Sublingual immunotherapy for treating allergic conjunctivitis

hindawi.com — “While it is generally accepted that Subcutaneous Injection Immunotherapy (SCIT) and Sublingual Immunotherapy (SLIT) are both efficacious, there is not yet a significant amount of information regarding their comparative efficacy. In this paper, we performed a retrospective chart review and compared treatment results in two groups of patients (both with nasal allergies with or without asthma) that were treated either with SCIT or SLIT. Both treatment modalities were found to be of similar efficacy” View full resource at hindawi.com

Most Recently Shared on April 25, 2012 at 12:17 am By:

John Weiner Allergist, Physician, Doctor, and Internist

Full text US observational series of SCIT v SLIT in allergy. Useful data http://t.co/immH2CZJ

1 month ago...

Retweet

Favorite

Otolaryngology Article | Rhinitis, Allergic, Seasonal Conjunctivitis, Allergic

mdlinx.com — “Ultrashort-specific immunotherapy successfully treats seasonal allergic rhinoconjunctivitis to grass pollen” View full resource at mdlinx.com

Most Recently Shared on May 23, 2011 at 5:15 pm By:

Sandeep Pulim MD Doctor, Health Communicator, and Physician

Ultrashort-specific immunotherapy successfully treats seasonal allergic rhinoconjunctivitis to grass pollen... http://bit.ly/lIsxDv #ENT

1 year ago...

Retweet

Favorite

Merck Reports Results Of Phase III Study Of Investigational Oral Allergy Immunotherapy Tablet (AIT) In Patients Ages 5-17 With Grass Pollen Allergy

medicalnewstoday.com — “In new data from a Phase III study in 345 children and adolescents (ages 5-17 years), patients with grass pollen allergic rhinoconjunctivitis treated with Merck's investigational sublingual grass” View full resource at medicalnewstoday.com